Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 36 of BioAtla, Inc.'s SEC filings and found 2 warrant series, 1 convertible, 2 equity lines, 3 shelf registrations, 1 S-1 registration and 4 completed offerings on file for BCAB. The latest dilution event on file is a registration statement on Oct 29, 2026. Analysis updated Nov 4, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
KALAKALA BIO, Inc.
GRIGRI Bio, Inc.
ERNAErnexa Therapeutics Inc.
JUNSJupiter Neurosciences, Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
APVOAptevo Therapeutics Inc.
PMCBPharmaCyte Biotech, Inc.
CMNDClearmind Medicine Inc.
ONCOOnconetix, Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
HLSQTessera Defense and Homeland Security Inc
MDCXMedicus Pharma Ltd. Common Stock
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
CODXCo-Diagnostics, Inc.
ABPOAbpro Holdings, Inc.